BROS vs BTAI · P/E 105, rev $1.02B vs rev $388.0K
Dutch Bros Inc (BROS) versus BioXcel Therapeutics Inc (BTAI) — a side-by-side from cached financials, not a winner call.
Dutch Bros Inc (BROS) is a restaurants company listed on NYSE.
BioXcel Therapeutics Inc (BTAI) is a drug manufacturers - specialty & generic company listed on US.
Latest reported BROS revenue for 2026-06-30 was $1.02B. Net income was $53.5M. BROS currently screens at market cap $11.74B and trailing P/E 105.0.
Latest reported BTAI revenue for 2026-06-30 was $388.0K. Net income was -$27.4M. Revenue was up 88.3% from 2026-03-31 to 2026-06-30. BTAI currently screens at market cap $36.1M.
BROS currently screens at market cap $11.74B and trailing P/E 105.0. BTAI currently screens at market cap $36.1M.
Not investment advice. Open the BROS and BTAI stock pages for the full models.
Not investment advice.